References
- ACOG Committee on Practice Bulletins. ACOG practice bulletin no. 77: Screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217–227.
- American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 88, December 2007. invasive prenatal testing for aneuploidy. Obstet Gynecol 2007;110:1459–1467.
- Chasen ST, McCullough LB, Chervenak FA. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population? Am J Obstet Gynecol 2004;190:769–774.
- Nadel AS, Likhite ML. Impact of first-trimester aneuploidy screening in a high-risk population. Fetal Diagn Ther 2009;26:29–34.
- Zoppi MA, Ibba RM, Putzolu M, Floris M, Monni G. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older. Obstet Gynecol 2001;97:916–920.
- Wasden SW, Adams BN, Chasen ST. Are age cutoffs still used to identify candidates for invasive testing for chromosomal abnormalities? J Reprod Med 2011;56:113–116.
- [Internet]. Available at: http://www.genzymegenetics.com/Our- Services/Reproductive-Testing/sequential-screening.aspx.
- Wagner D, Pargas C, Donnenfeld AE. Moderately increased risks of Down’s syndrome (1/51–1/270) identified on first trimester sequential screening: What do patients do with this information? J Med Screen 2010;17:4–7.
- Benn PA, Egan JF, Fang M, Smith-Bindman R. Changes in the utilization of prenatal diagnosis. Obstet Gynecol 2004;103:1255–1260.
- Marttala J, Ranta JK, Kaijomaa M, Nieminen P, Laitinen P, Kokkonen H, Romppanen J, et al. More invasive procedures are done to detect each case of Down’s syndrome in younger women. Acta Obstet Gynecol Scand 2011;90:642–647.
- Kalousek DK, Vekemans M. Confined placental mosaicism. J Med Genet 1996;33:529–533.